<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-054017</identifier>
<setSpec>0301-0546</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Hypocomplementemia in the absence of autoantibodies in women with recurrent pregnancy loss</dc:title>
<dc:description xml:lang="en">Background. Accumulating data suggest an immunopathogenic role for the complement system as a causative element in pregnancy loss (PL). Formation of pathogenic antibodies with activation of the classical pathway may have a role, but this mechanism fails to characterize the majority of cases with recurrent PL. We established the prevalence of hypocomplementemia without circulating autoantibodies in women with recurrent PL.                 Methods: In a retrospective case control study, 201 women with recurrent PL (two or more PL) and 30 healthy women who had normal pregnancies but no PL were studied. Serum levels of C3, C4, and factor B were determined by nephelometry. Total hemolytic activity of the complement system (CH100) was investigated by radial immunodiffusion test.                 Results: The prevalence of hypocomplementemia [low levels of C3, C4, FB or CH100 (with normal concentrations of C3, C4 and FB)] was significantly higher in women with recurrent PL (22,4 %) in comparison with controls (6.6 %; p = 0.019). C3, C4, FB hypocomplementemia or low CH100 were observed in 13 (6,5 %), 19 (9,4 %), 13 (6.5 %) and 7 (3,5 %) women with recurrent PL, respectively. Among patients with C3, C4, FB or CH100 hypocomplementemia, 10, 18, 12 and 5 patients had no circulating autoantibodies [antinuclear antibodies, anticardiolipin antibodies or antithyroid antibodies], respectively. In all, hypocomplementemia, in the absence of autoantibodies, was observed in 38 (18,9 %) women with recurrent PL in a significantly higher frequency than controls (n = 2, p = 0.049).                 Conclusions: Hypocomplementemia, in the absence of autoantibodies was observed in a group of women with recurrent PL which might suggest a role of the complement system in the pathogenesis of PL in these patients</dc:description>
<dc:creator>Fernández-Cruz, E</dc:creator>
<dc:creator>Teijeiro, R</dc:creator>
<dc:creator>Jensen, J</dc:creator>
<dc:creator>Rodríguez Molina, JJ</dc:creator>
<dc:creator>Micheloud, D</dc:creator>
<dc:creator>Carbone, J</dc:creator>
<dc:creator>Sarmiento, E</dc:creator>
<dc:language>en</dc:language>
<dc:description xml:lang="es">Antecedentes. Un cúmulo de datos sugiere que el sistema complemento juega un papel destacado como elemento inmunopatogénico en la interrupción espontánea del embarazo. La formación de anticuerpos patógenos que activen la vía clásica del complemento puede jugar un papel, pero este mecanismo falla al caracterizar la mayoría de los casos de aborto recurrente. Nosotros establecemos la prevalencia de la hipocomplementemia sin anticuerpos circulantes en mujeres con abortos recurrentes. Métodos. En un estudio retrospectivo se estudiaron 201 mujeres con aborto recurrente (2 o más abortos) y 30 mujeres sanas que habían tenido embarazos normales, pero no abortos. Por nefelometría se valoraron los niveles de C3, C4 y factor B. La actividad del sistema complemento (CH100) se estudio por inmunodifusión radial. Resultados. La prevalencia de hypocomplementemia (niveles bajos de C3, C4, FB o CH100 &#150;con concentraciones normales de C3, C4 y FB) fue significativamente más elevada en mujeres con aborto recurrente (22,4%) en comparación con los controles (6,6%; p=0.019). C3, C4, hypocomplementemia FB o CH100 bajo, se observaron respectivamente en 13 (6,6%), 19 (9,4%), 13 (6,5%) y 7 (3,5%) de mujeres con abortos repetidos. Entre las pacientes con C3, C4, FB o CH100 hipocomplementemia, 10, 18, 12 y 5, respectivamente no tenían autoanticuerpos circulantes (anticuerpos antinucleares, anticardiolipina o antitiroides). En todas, hipocomplementemia en ausencia de autoanticuerpos, se observó en 38 (18,9%) mujeres con aborto recurrente y con una significativa mayor frecuencia que en los controles (n=2, p=0.049). Conclusiones. Hipocomplementemia en ausencia de autoanticuerpos se observó en un grupo de mujeres con aborto recurrente, lo que podría sugerir el papel del sistema complemento en la patogénesis de los abortos de estas pacientes</dc:description>
<dc:source>Allergol Immunopathol (Madr);35(3): 90-94, mayo 2007. tab</dc:source>
<dc:identifier>ibc-054017</dc:identifier>
<dc:title xml:lang="es">Hipocomplementemia en ausencia de autoanticuerpos en mujeres con abortos repetidos</dc:title>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d22132^s22038</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d25^s22027</dc:subject>
<dc:subject>^d22132^s22015</dc:subject>
<dc:subject>^d25^s22038</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1329^s22038</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>200705</dc:date>
</metadata>
</record>
</ibecs-document>
